Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 75

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 75
---
036,659 Shares of Common Stock

or

Up to 2,036,659 Pre-Funded Warrants to Purchase up to 2,036,659 Shares of Common Stock
Series A-1 Warrants to Purchase up to 2,036,659 Shares of Common Stock
Series A-2 Warrants to Purchase up to 2,036,659 Shares of Common Stock

Up to 6,109,977 ]Shares of Common Stock Issuable Upon Exercise of the Series A-1 Warrants, Series A-2 Warrants and Pre-Funded Warrants

60 Degrees Pharmaceuticals, Inc.

PRELIMINARY PROSPECTUS

H.C. Wainwright & Co.

,
2025

Part II

INFORMATION NOT REQUIRED IN PROSPECTUS</div>

Item 13. Other Expenses of Issuance and Distribution.

The following table indicates the expenses to
be incurred in connection with the offering described in this registration statement, other than underwriter fees, all of which will be
paid by us. All amounts are estimated except the Securities and Exchange Commission (“SEC”) registration fee and the Financial
Industry Regulatory Authority, Inc. (“FINRA”) filing fee.

|                                |     | Amount |            |
|:-------------------------------|:----|:-------|-----------:|
| SEC registration fee           |     | $      |   2,368.27 |
| FINRA filing fee               |     |        |      1,250 |
| Accountants’ fees and expenses |     |        |     50,000 |
| Legal fees and expenses        |     |        |    225,000 |
| Miscellaneous                  |     |        |    165,000 |
| Total expenses                 |     | $      | 443,618.27 |

Item 14. Indemnification of Directors and Officers.

Section 102 of the General Company Law of the
State of Delaware (“DGCL”) permits a company to eliminate the personal liability of directors of a company to the company
or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his duty of
loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend
or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. Our charter provides that
none of our directors shall be personally liable to it or its stockholders for monetary